Claus G. Roehrborn

After attending medical school in Giessen, Germany, Claus G. Roehrborn, M.D., began his residency in surgery and urology at the German Army Hospital in Giessen. He continued his urology residency at the University of Texas Southwestern Medical Center and joined the UT Southwestern Medical Center staff in 1992. His research and clinical practice have focused on benign and malignant prostatic diseases throughout his career. In the 1990s he was involved in the first-ever evidence-based guidelines on the management of benign prostatic hyperplasia (BPH) in the U.S., and he chaired committees at the World Health Organization-sponsored Consensus Conferences on BPH as well. His more than 300 peer-reviewed publications are representative of his work in prostate cancer and male voiding dysfunction, and at present, Dr. Roehrborn’s research is focused on virtually all aspects of BPH research as well as translational and clinical research in prostate cancer. His clinical practice focuses on the management of localized as well as advanced prostate cancer and BPH, and he has established expertise and large practice in robotic-assisted prostatectomies.